Brain MR Imaging Abnormalities in Kidney Transplant Recipients

References

1. ↵
   Donaghy M. Neurological complications. In: Morris PJ, ed. Kidney transplant. Philadelphia: Saunders;2001 :533–540
2. ↵
   Snanoudj R, Kriaa F, Arzouk N, et al. Single center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients. Transplant Proc 2004;36:183–188
3. ↵
   Donaghy M. Neurologic considerations of organ transplantation. In: Ginnus LC, Cosimi AB, Morrris PJ, eds. Transplantation. Malden, MA: Blackwell;1999 :696–707
4. ↵
   Adams HP, Dawson G, Coffman TJ, Corry JR. Stroke in renal transplant recipients. Arch Neurol 1986;43:113–115

   CrossRefPubMedWeb of Science
5. ↵
   Gupta SK, Manjunath-Prasad KS, Sharma BS, et al. Brain abscess in renal transplant recipients: report of three cases. Surg Neurol 1997;48:284–287

   CrossRefPubMedWeb of Science
6. ↵
   Shin JH, Lee HK. Nocardial brain abscess in a renal transplant recipient. Clin Imaging 2003;27:321–324

   CrossRefPubMedWeb of Science
7. Renoult E, Georges E, Biava MF, et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis 1997;24:625–634

   Abstract/FREE Full Text
8. ↵
   Snanoudj R, Durrbach A, Leblond V, et al. Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation 2003;76:930–937

   CrossRefPubMedWeb of Science
9. ↵
   Thanh GP, O’Neill BP, Kurtin PJ. Posttransplant primary CNS lymphoma. Neurooncol 2000;2:229–238

   Abstract/FREE Full Text
10. ↵
    Miller WT, Siegel SG, Montone KT. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. Crit Rev Diagn Imaging 1997;38:569–585

    PubMedWeb of Science
11. ↵
    Kaphan E, Eusebio A, Witjas T, et al. Primary leiomyosarcoma of the cavernous sinus associated with Epstein-Barr virus in kidney graft. Rev Neurol 2003;159:1055–1059

    PubMed
12. ↵
    Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000;69:467–472

    CrossRefPubMedWeb of Science
13. ↵
    Garcia-Escrig M, Martinez J, Fernandez-Ponsati J, et al. Severe central nervous system toxicity after chronic treatment with cyclosporine. Clin Neuropharmacol 1994;17:298–302

    PubMed
14. ↵
    Wijdicks EFM. Neurotoxicity of immunosuppressive drugs. Liver Transpl 2001;7:937–942

    CrossRefPubMedWeb of Science
15. ↵
    Kiemeneij IM, de Leeuw FE, Ramos LM, van Gijn. Acute headache as a presenting symptom of tacrolimus encephalopathy. J Neurol Neurosurg Psychiatry 2003;74:1126–1127

    Abstract/FREE Full Text
16. ↵
    Drachman BM, DeNofrio D, Acker MA, et al. Cortical blindness secondary to cyclosporine after orthotopic heart transplantation: a case report and review of the literature. J Heart Lung Transplant 1996;15:1158–1164

    PubMedWeb of Science
17. ↵
    Lanzino G, Cloft H, Hemstreet MK, et al. Reversible posterior leukoencephalopathy following organ transplantation: description of two cases. Clin Neurol Neurosurg 1997;99:222–226

    CrossRefPubMedWeb of Science
18. ↵
    Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 1996;166:683–688

    PubMedWeb of Science
19. ↵
    Shimono T, Miki Y, Toyoda H, et al. MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients. Eur Radiol 2003;13:986–993

    PubMedWeb of Science
20. ↵
    Furukawa M, Terae S, Chu BC, et al. MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging. Neuroradiology 2001;43:615–621

    CrossRefPubMedWeb of Science
21. ↵
    Jarosz JM, Howlett DC, Cox TCS, Bingham JB. Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 1997;39:711–715

    CrossRefPubMedWeb of Science
22. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627–631

    CrossRefPubMedWeb of Science
23. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199–1206

    Abstract/FREE Full Text
24. Scheinman SJ, Reinitz ER, Petro G, et al. Cyclosporine central neurotoxicity following renal transplantation: report of a case using magnetic resonance images. Transplantation 1990;49:215–216

    PubMed
25. Dedeoglu O, Springate JE, Najdzionek JS, Feld LG. Hypertensive encephalopathy and reversible magnetic resonance imaging changes in a renal transplant patient. Pediatr Nephrol 1996;10:769–771

    CrossRefPubMedWeb of Science
26. Jeruss J, Braun SV, Reese JC, Guillot A. Cyclosporine-induced white and gray matter central nervous system lesions in a pediatric renal transplant patient. Pediatr Transplant 1998;2:45–50

    PubMed
27. Parvex P, Pinsk M, Bell LE, et al. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 2001;16:537–542

    CrossRefPubMedWeb of Science
28. ↵
    Okoshi Y, Itoh M, Okimoto Y, et al. A case of FK 506-induced leukoencephalopathy. No To Shinkei 2002;54:51–55

    PubMed
29. ↵
    Debaere C, Stadnik T, De Maeseneer M, Osteaux M. Diffusion-weighted MRI in cyclosporine A neurotoxicity for the classification of cerebral edema. Eur Radiol 1999;9:1916–1918

    CrossRefPubMed
30. ↵
    Bartinsky WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997;21:872–880

    CrossRefPubMed
31. ↵
    Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901–1914

    Abstract/FREE Full Text
32. ↵
    Bartynski WS, Zeigler ZR, Shadduck RK, Lister J. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogenic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261–269

    Abstract/FREE Full Text
33. ↵
    Lewis MB, Howdle PD. Neurologic complications of liver transplantation in adults. Neurology 2003;61:1174–1178

    Abstract/FREE Full Text
34. ↵
    Bargallo N, Burrel M, Berenguer J, et al. Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. AJNR Am J Neuroradiol 2000;21:479–284

    Abstract/FREE Full Text